Duodenal Polyposis

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2011-07-06
Clinical Trial Update: Coxib-inhibition of Duodenal Polyp Growth in FAP [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating a COX-2 inhibitor (coxib) for reducing duodenal polyps in patients with familial adenomatous pol…